CLB
insider transactionsCore Laboratories Inc. /DE/ — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·M
SVP, Gen Counsel & Secretary
$0
250 sh
Own +26%
-
Exercise·M
SVP, Gen Counsel & Secretary
$0
250 sh
Own +1%
-
Other·F
SVP, Gen Counsel & Secretary
$1.4K
97 sh · $14.07
Own -0%
-
Exercise·M
Director
$0
8.1K sh
Own New
-
Grant·A
Director
$0
7.9K sh
Own New
-
Exercise·M
Director
$0
8.1K sh
Own +19%
-
Exercise·M
Director
$0
8.1K sh
Own New
-
Grant·A
Director
$0
7.9K sh
Own New
-
Exercise·M
Director
$0
8.1K sh
Own +32%
-
Exercise·M
Director
$0
8.1K sh
Own New
-
Grant·A
Director
$0
7.9K sh
Own New
-
Exercise·M
Director
$0
8.1K sh
Own New
-
Exercise·M
Director
$0
8.1K sh
Own New
-
Grant·A
Director
$0
7.9K sh
Own New
-
Exercise·M
Director
$0
8.1K sh
Own +38%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 1, 2026 | Mark Damian Tattoli | Exercise M | 250 | $0 |
| May 1, 2026 | Mark Damian Tattoli | Exercise M | 250 | $0 |
| May 1, 2026 | Mark Damian Tattoli | Other F | 97 | $1.4K |
| Apr 1, 2026 | Harvey Robert Klingensmith | Exercise M | 8.1K | $0 |
| Apr 1, 2026 | Harvey Robert Klingensmith | Grant A | 7.9K | $0 |
| Apr 1, 2026 | Harvey Robert Klingensmith | Exercise M | 8.1K | $0 |
| Apr 1, 2026 | Kwaku Temeng | Exercise M | 8.1K | $0 |
| Apr 1, 2026 | Kwaku Temeng | Grant A | 7.9K | $0 |
| Apr 1, 2026 | Kwaku Temeng | Exercise M | 8.1K | $0 |
| Apr 1, 2026 | Robert F Martinovich | Exercise M | 8.1K | $0 |
| Apr 1, 2026 | Robert F Martinovich | Grant A | 7.9K | $0 |
| Apr 1, 2026 | Robert F Martinovich | Exercise M | 8.1K | $0 |
| Apr 1, 2026 | Katherine Murray | Exercise M | 8.1K | $0 |
| Apr 1, 2026 | Katherine Murray | Grant A | 7.9K | $0 |
| Apr 1, 2026 | Katherine Murray | Exercise M | 8.1K | $0 |
About CLB insider trading
This page tracks insider transactions for Core Laboratories Inc. /DE/ (CLB) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.